There are several clear benefits of regional anesthesia for surgical procedures. However, patients with pre-existing neurologic disorders create a unique challenge for the anesthesia provider considering the use of regional or neuraxial anesthesia. Specifically, patients with autoimmune mediated neurologic disorders that possess pre-existing neurologic deficits have been thought to be at a higher risk for neural compromise and therefore, are often excluded from the use of regional anesthesia [1]. In all cases where regional anesthesia is considered, the benefits must be weighed against potential complications; the greatest risk being a new or worsened neurologic deficit. With the advancement of regional techniques paired with ultrasound guidance, literature suggests that belonging to this patient population should not necessarily be a contraindication to regional anesthesia [2]. Due to the medicolegal concerns and historic avoidance of regional anesthesia in patients with neurologic disorders, there is a lack of discussion and studies in the United States on this topic. However, increasing support for the use of regional anesthesia for surgical procedures has produced a few studies within the United States and gained even more popularity internationally. This article will explain the pathophysiology of multiple sclerosis, evaluate current anesthetic practices and recent literature on regional anesthesia for patients with this disorder and provide recommendations for further studies and practice guidelines. After reading this article the reader will be able to properly identify and assess patients at an increased risk for neurologic compromise,